Maraviroc, a C‐C chemokine receptor type 5 (CCR5) antagonist, prevented ST3G5high‐cExo‐mediated MMT, T‐cell suppression, and metastasis in MSs. This evidence concerns the gene CCR5 and Marinesco-Sjogren syndrome.